loading

Wave Life Sciences Ltd (WVE) 最新ニュース

pulisher
Mar 31, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer faces challenges in genetic medicine stock - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

What is Leerink Partnrs’ Estimate for WVE Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

HC Wainwright Reaffirms “Buy” Rating for Wave Life Sciences (NASDAQ:WVE) - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (NASDAQ:WVE) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

WAVE Life Sciences stock holds buy rating, $22 target from H.C. Wainwright - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Wave Life Sciences reports progress in DMD treatment By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Aspires To Accelerated Approval In DMD With 48-Week Data - insights.citeline.com

Mar 26, 2025
pulisher
Mar 26, 2025

Riding the Wave, exon skipper sails toward DMD filing - BioWorld Online

Mar 26, 2025
pulisher
Mar 26, 2025

Sector Update: Health Care Stocks Retreat Wednesday Afternoon - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Jefferies maintains Buy on WAVE Life Sciences stock, $26 target By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences to submit Duchenne drug for approval after Phase 2 success - The Boston Globe

Mar 26, 2025
pulisher
Mar 26, 2025

Jefferies maintains Buy on WAVE Life Sciences stock, $26 target - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Wave to seek FDA accelerated approval for Duchenne candidate in 2026 - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences shares surge on positive DMD trial results By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences shares surge on positive DMD trial results - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences reports progress in DMD treatment - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences Reports Positive Phase 2 Trial Results - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Wave Life Sciences Announces Positive Data from FORWARD-53 - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Clinical Trial Breakthrough: New DMD Drug Achieves Unprecedented Muscle Recovery - StockTitan

Mar 26, 2025
pulisher
Mar 24, 2025

Victory Capital Management Inc. Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Charles Schwab Investment Management Inc. Grows Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Wave Life Sciences director Christian Henry sells $102,574 in shares By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Wave Life Sciences director Christian Henry sells $102,574 in shares - Investing.com

Mar 21, 2025
pulisher
Mar 20, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

US Bancorp DE Cuts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 18, 2025
pulisher
Mar 16, 2025

Arizona State Retirement System Acquires 7,846 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

How To Trade (WVE) - Stock Traders Daily

Mar 15, 2025
pulisher
Mar 12, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com

Mar 12, 2025
pulisher
Mar 10, 2025

Mizuho maintains WAVE Life Sciences Outperform rating - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Paul Bolno Sells 169,025 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

HC Wainwright Cuts Earnings Estimates for Wave Life Sciences - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Q1 EPS Forecast for Wave Life Sciences Decreased by Analyst - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Wave Life Sciences (NASDAQ:WVE) Rating Increased to Hold at StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Commit To Purchase Wave Life Sciences At $7.50, Earn 25.6% Annualized Using Options - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

Wave Life Sciences (NASDAQ:WVE) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Analysts Set Expectations for WVE Q1 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com India

Mar 06, 2025
pulisher
Mar 05, 2025

Wave Life Sciences’ Earnings Call Highlights Progress and Challenges - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Truist maintains Buy rating on WAVE Life Sciences stock, $36 target By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

RBC Trims Price Target on Wave Life Sciences to $14 From $15, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Buys 17,316 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... By GuruFocus - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Y Intercept Hong Kong Ltd Sells 6,875 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Principal Financial Group Inc. Buys Shares of 248,645 Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: R - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... - Yahoo Finance

Mar 05, 2025
$67.93
price down icon 0.38%
$72.28
price down icon 0.94%
$31.18
price up icon 0.02%
$18.78
price down icon 0.05%
$89.09
price down icon 1.62%
biotechnology ONC
$272.36
price up icon 0.53%
大文字化:     |  ボリューム (24 時間):